patient-centric

R&D

One year on: How is the UK’s vision of a future-proof resear...

One year ago, a UK-wide vision for the country’s future research landscape promised streamlined processes, and a patient-centred, competitive environment.

Views & Analysis

LEO Pharma’s new R&D lead on driving agility in drug develop...

After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development.

Views & Analysis

Getting patients round the virtual table

If pharma wants to be truly patient-centric, it needs to be talking to patients.

Partner Content

Partner Content

Placing the patient at the centre

There’s much talk about patient-centric trials – collecting feedback and insight from patients and incorporating it into study designs in a quantifiable way is key to ensuring success, expl

Views & Analysis